Macquarie Group Ltd. Purchases 9,163 Shares of Phreesia, Inc. (NYSE:PHR)

Macquarie Group Ltd. lifted its position in Phreesia, Inc. (NYSE:PHR – Get Rating) by 11.6% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 87,952 shares of the company’s stock after purchasing an additional 9,163 shares during the period. Macquarie Group Ltd. owned about 0.17% of Phreesia worth $2,268,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Rockefeller Capital Management L.P. grew its holdings in shares of Phreesia by 610.2% in the third quarter. Rockefeller Capital Management L.P. now owns 4,524 shares of the company’s stock worth $115,000 after purchasing an additional 3,887 shares during the last quarter. Pictet Asset Management SA grew its holdings in shares of Phreesia by 33.9% in the second quarter. Pictet Asset Management SA now owns 69,998 shares of the company’s stock worth $1,751,000 after purchasing an additional 17,706 shares during the last quarter. Jennison Associates LLC lifted its stake in Phreesia by 55.1% in the third quarter. Jennison Associates LLC now owns 1,110,942 shares of the company’s stock worth $28,307,000 after acquiring an additional 394,599 shares during the period. Segall Bryant & Hamill LLC lifted its stake in Phreesia by 11.5% in the third quarter. Segall Bryant & Hamill LLC now owns 228,617 shares of the company’s stock worth $5,824,000 after acquiring an additional 23,631 shares during the period. Finally, BloombergSen Inc. lifted its stake in Phreesia by 57.1% in the second quarter. BloombergSen Inc. now owns 5,500 shares of the company’s stock worth $138,000 after acquiring an additional 2,000 shares during the period. Institutional investors own 92.23% of the company’s stock.

Insider Transactions at Phreesia

In other news, CFO Randy Rasmussen sold 4,765 shares of Phreesia stock in a transaction dated Thursday, February 2nd. The stock was sold at an average price of $40.00, for a total value of $190,600.00. Following the completion of the transaction, the chief financial officer now owns 145,594 shares of the company’s stock, valued at approximately $5,823,760. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In related news, General Counsel Allison C. Hoffman sold 3,109 shares of Phreesia stock in a transaction dated Tuesday, December 13th. The stock was sold at an average price of $34.40, for a total value of $106,949.60. Following the completion of the sale, the general counsel now directly owns 103,063 shares in the company, valued at approximately $3,545,367.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CFO Randy Rasmussen sold 4,765 shares of Phreesia stock in a transaction dated Thursday, February 2nd. The stock was sold at an average price of $40.00, for a total value of $190,600.00. Following the completion of the sale, the chief financial officer now owns 145,594 shares of the company’s stock, valued at $5,823,760. The disclosure for this sale can be found here. Insiders sold a total of 67,606 shares of company stock valued at $2,443,241 in the last quarter. 5.50% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

PHR has been the subject of a number of research analyst reports. Needham & Company LLC raised their price target on Phreesia from $35.00 to $40.00 and gave the stock a “buy” rating in a research note on Wednesday, January 4th. KeyCorp raised their price target on Phreesia from $40.00 to $45.00 and gave the stock an “overweight” rating in a research note on Thursday, February 2nd. SVB Leerink raised their price target on Phreesia from $34.00 to $39.00 and gave the stock an “outperform” rating in a research note on Thursday, January 5th. Piper Sandler raised their price target on Phreesia from $37.00 to $43.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 25th. Finally, Robert W. Baird raised their price objective on Phreesia to $41.00 in a research report on Wednesday, December 14th. Two investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. According to MarketBeat, Phreesia currently has a consensus rating of “Moderate Buy” and a consensus target price of $37.07.

Phreesia Price Performance

PHR opened at $34.75 on Friday. The stock has a 50-day moving average price of $35.85 and a 200-day moving average price of $29.79. The company has a debt-to-equity ratio of 0.01, a current ratio of 3.94 and a quick ratio of 3.94. The firm has a market cap of $1.83 billion, a PE ratio of -9.82 and a beta of 0.65. Phreesia, Inc. has a 1 year low of $13.19 and a 1 year high of $40.00.

Phreesia (NYSE:PHR – Get Rating) last posted its quarterly earnings results on Thursday, December 8th. The company reported ($0.76) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.88) by $0.12. The firm had revenue of $73.10 million during the quarter, compared to analyst estimates of $71.16 million. Phreesia had a negative return on equity of 50.32% and a negative net margin of 70.36%. Sell-side analysts predict that Phreesia, Inc. will post -3.43 earnings per share for the current fiscal year.

About Phreesia

(Get Rating)

Phreesia, Inc is a healthcare software company, which engages in the provision of patient check-in solutions for medical practices. The firm offers appointments, clinical support, integration, registration, patient activation, analytics and reports, revenue cycle, patient surveys, and privacy and security products.